Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cancer(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women. Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).
In Traditional Chinese Medicine Perspective
While conventional medicine focus of using synthetic medication to induce ovulation and assisted artificial insemination for infertility couple, if the medicine fail, traditional Chinese medicine views polycystic ovarian syndrome in different approaches. Polycystic ovary syndrome, according to traditional Chinese medicine is a medical condition characterized by accumulative of fluid over a prolonged period of time causes of dampness and phlegms(1247a)(1247b) build up on the ovaries due to the effects of vary differentiations, affecting not only the women’s menstrual cycle, but also ovulation and fertility(1247a)(1247b).
PCOs Treatment according traditional Chinese medicine
Depending to differentiation, most common diagnosis of polycystic ovary syndrome can be classified into
Spleen yang deficiency
Spleen yang deficiency is a serve form of spleen qi deficiency, characterized by a condition of inability of spleen in distribution of fluid and nutrient to the body organs, in removal and descend the turbids(2072), causing malfunctions functions of the organs and fluid retention. Prolong period of spleen yang deficiency may induce the development of phlegm, including women with PCOs.
Women with PCOs diagnosed by spleen yang deficiency may also experience yang vacuity impelled cold expression of additional symptoms of abdominal pain(2074), lack of appetite(2076), fatigue(2075), lightheadedness(2075) and headache(2075), weakness of the four limbs(2077), diarrhea(2073)(2076), chilliness(2077), edema(2074), pale, swollen, wet tongue(2076) and weak, slow, deep pulse(2072),....
In the review of the Data base provided by PubMed, spleen qi deficiency may alter certain metabolic pathways, such as the energy, protein, and glycolytic metabolisms(2078), body weight and motor behavior(2079), skeletal muscle function(3080), blood glucose, lipid metabolism and fat-islet axie.(2081),.....
Women with PCOs diagnosed by spleen yang deficiency may also experience yang vacuity impelled cold expression of additional symptoms of abdominal pain(2074), lack of appetite(2076), fatigue(2075), lightheadedness(2075) and headache(2075), weakness of the four limbs(2077), diarrhea(2073)(2076), chilliness(2077), edema(2074), pale, swollen, wet tongue(2076) and weak, slow, deep pulse(2072),....
In the review of the Data base provided by PubMed, spleen qi deficiency may alter certain metabolic pathways, such as the energy, protein, and glycolytic metabolisms(2078), body weight and motor behavior(2079), skeletal muscle function(3080), blood glucose, lipid metabolism and fat-islet axie.(2081),.....
Foods for Spleen yang deficiency
Spleen yang deficiency can be managed and treated in part with a diet of fresh and cooked warming foods.
3. Garlic
Garlic (Allium sativum) is a species in the onion genus, belonging to family Amaryllidaceae, native to central Asia. It has been used popularly in traditional and Chinese medicine in treating common cold(1587)(1588) and flu(1589)(1590), blood pressure(1591)(1592), cholesterol levels(1593)(1594), natural antibiotic(1595)(1596), cancers(1597)(1598)(1599) etc....(1585).
According to traditional Chinese medicine, the acrid, warm herbal da suan expresses its tonification of yang through enhancing function of large intestine, lung, spleen, stomach channels(1586).
Chemical constituents(1586)
1. Allyl methyl sulfide
2. Diallyl sulfide
3. 6-methyl-1-thio-2
4. 4-cyclohexadiene
5. Dimethyl sulfide
6. Divinyl sulfide
7. Dimethyl disulfide
8. Allyl methyl disulfide
9. Dithiocyclopentene
10. 5-methyl-1
11. 2-dithio-3-cyclopentene
12. Allyl propyl disulfide
13. 2-dithio-3-cyclopentene
14. 4-methyl-1
15. 3-vinyl-1
16. 2-dithio-4-cyclohexene
17. 3-vinyl-1
18. 2-dithio-5 cyclohexene
19. Cysteine,
20. Histidine
21. Lysine
22. Etc.
Epidemiological literature suggested that garlic also displays anti metabolic syndrome(1602)(1603), including obesity(16000)(1601), elevated blood pressure(1591)(1592), elevated fasting plasma glucose(1604)(1605), high serum triglycerides(1604)(1602), and low high-density lipoprotein (HDL)(1593)(1594)(1604) levels, insulin resistance(1606)(1607), proinflammation(1609)(1608) and renal damage(1610)(1611), reduced risk of cardiovascular disease(1612)(1613) and diabetes, probably through its effects on carbohydrate and lipid(1601) modulation via anti inflammatory(1606) and antioxidant(1603)(1606) mechanisms. All these factors may be the reasons of which garlic was recommended by modern traditional Chinese medicine doctors for management and treatment of PCOs' women who were diagnosed with kidney yang deficiency.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) bny by Liqin Zhao
(2072) Spleen, Earth
(2073) [Research on building method of spleen kidney Yang deficiency diarrhea rats model]. [Article in Chinese] by Pan X, Hu CJ, Geng YY, Zhao L, Wu WH, Wu XQ, Zhong ZD.(PubMed)
(2074) Treatment of an elderly patient with acute abdominal pain with traditional Korean medicine by Son CG1.(PubMed)
(2075) Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial by Fang Z1, Zhao J2, Shi G3, Shu Y3, Ni Y3, Wang H3, Ding L3, Lu R3, Li J3, Zhu X3, Cheng S4, Zhang X3, Liu Y5, Wang J6, Luo Y3, Fan Q3, Guo C3, Jiang T3, Wu Q3, Fan L3, Ling H3, Cui L3, Luo Y3, Yang H3, Anderson RM7.(PubMed)
(2075) Direct moxibustion to treat spleen qi and yang deficiency fatigue: a pilot study by Thorne TL1, Hanes DA2, Wild H3, Colbert A4.(PubMed)
(2076) [Clinical observation on fuzhong (supporting the middle-jiao) manipulation of tuina for infantile anorexia]. [Article in Chinese] by Wang YY, Liu XY.(PubMed)
(2077) [Effect of umbilicus moxibustion therapy on physical conditions of yang-deficiency volunteers]. [Article in Chinese] by Zhang YY1.(PubMed)
(2078) Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics by Zheng XF1, Tian JS2, Liu P3, Xing J1, Qin XM1.(PubMed)
(2079) [1H NMR based metabolomics study of bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model]. [Article in Chinese] by Chen L, Xiang H, Xing J, Tian JS, Qin XM, Du GH.(PubMed)
(2080) Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease by Dong Y1,2, Li Y3,4,5, Sun Y6, Mao J7, Yao F8, Tian Y9, Wang L10, Li L11, Li S12,13,14, Li J15,16,17(PubMed)
(2081) [Clinical observation on obesity and hyperlipidemia of liver qi stagnation and spleen deficiency pattern in female patients treated with combined therapy of acupuncture and tapping method]. [Article in Chinese] by Wu B, Liu ZC, Xu B.(PubMed)
(1585) Popular #Herbs - #Garlic (Allium sativum) by Kyle J. Norton
(1586) Da Suan, Garlic(Complementary and Alternative Healing University)
(1587) Garlic for the common cold by Lissiman E1, Bhasale AL, Cohen M.(PubMed)
(1588) Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey by Josling P1.(PubMed)
(1589) Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention by Nantz MP1, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS.(PubMed)
(1590)A strategic call to utilize Echinacea-garlic in flu-cold seasons by Abdullah T.(PubMed)
(1591) Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials by Xiong XJ1, Wang PQ2, Li SJ3, Li XK4, Zhang YQ5, Wang J6.(PubMed)
(1592) Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial by Ried K1, Frank OR, Stocks NP.(PubMed)
(1593) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies by Yeh YY1, Liu L.(PubMed)
(1594) Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic by Liu L1, Yeh YY.(PubMed)
(1595) A comparison of the antimicrobial activity of garlic, ginger, carrot, and turmeric pastes against Escherichia coli O157:H7 in laboratory buffer and ground beef by Gupta S1, Ravishankar S.(PubMed)
(1596) Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms by Groppo FC1, Ramacciato JC, Simões RP, Flório FM, Sartoratto A.(PubMed)
(1597) Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers by Fleischauer AT1, Poole C, Arab L.(PubMed)
(1598) Garlic and cancer: a critical review of the epidemiologic literature by Fleischauer AT1, Arab L.(PubMed)
(1599) Consumption of garlic and risk of colorectal cancer: an updated meta-analysis of prospective studies by Hu JY1, Hu YW1, Zhou JJ1, Zhang MW1, Li D1, Zheng S1.(PubMed)
(1600) Effect of garlic on high fat induced obesity by Kim MJ1, Kim HK.(PubMed)
(1601) Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress by Lai YS1, Chen WC, Ho CT, Lu KH, Lin SH, Tseng HC, Lin SY, Sheen LY.(PubMed)
(1602) Potential protective effects of Nigella sativa and Allium sativum against fructose-induced metabolic syndrome in rats by Al-Rasheed N1, Al-Rasheed N, Bassiouni Y, Faddah L, Mohamad AM.(PubMed)
(1603) Medicinal agents and metabolic syndrome by Rubio-Ruiz ME1, El Hafidi M, Pérez-Torres I, Baños G, Guarner V.(PubMed)
(1604) Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides by Thomson M1, Al-Qattan KK, Bordia T, Ali M.(PubMed)
(1605) Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subjects by Bakhsh R, Chughtai MI.(PubMed)
(1606) Attenuation of oxidative stress, inflammation and insulin resistance by allium sativum in fructose-fed male rats by K S1, Senthilkumar GP, Sankar P, Bobby Z.(PubMed)
(1607) Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats by Padiya R1, Khatua TN, Bagul PK, Kuncha M, Banerjee SK.(PubMed)
(1608) Alliin, a garlic (Allium sativum) compound, prevents LPS-inducedinflammation in 3T3-L1 adipocytes by Quintero-Fabián S1, Ortuño-Sahagún D2, Vázquez-Carrera M3, López-Roa RI4.(PubMed)
(1609) Diallyl trisulfide ameliorates arsenic-induced hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats by Sumedha NC1, Miltonprabu S2.(PubMed)
(1610) Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats by Maldonado PD1, Barrera D, Medina-Campos ON, Hernández-Pando R, Ibarra-Rubio ME, Pedraza-Chaverrí J.(PubMed)
(1611) Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage by Maldonado PD1, Barrera D, Rivero I, Mata R, Medina-Campos ON, Hernández-Pando R, Pedraza-Chaverrí J.(PubMed)
(1612) Garlic and cardiovascular disease: a critical review by Rahman K1, Lowe GM.(PubMed)
(1613) Role of garlic usage in cardiovascular disease prevention: an evidence-based approach by Qidwai W1, Ashfaq T.(PubMed)
According to traditional Chinese medicine, the acrid, warm herbal da suan expresses its tonification of yang through enhancing function of large intestine, lung, spleen, stomach channels(1586).
Chemical constituents(1586)
1. Allyl methyl sulfide
2. Diallyl sulfide
3. 6-methyl-1-thio-2
4. 4-cyclohexadiene
5. Dimethyl sulfide
6. Divinyl sulfide
7. Dimethyl disulfide
8. Allyl methyl disulfide
9. Dithiocyclopentene
10. 5-methyl-1
11. 2-dithio-3-cyclopentene
12. Allyl propyl disulfide
13. 2-dithio-3-cyclopentene
14. 4-methyl-1
15. 3-vinyl-1
16. 2-dithio-4-cyclohexene
17. 3-vinyl-1
18. 2-dithio-5 cyclohexene
19. Cysteine,
20. Histidine
21. Lysine
22. Etc.
Epidemiological literature suggested that garlic also displays anti metabolic syndrome(1602)(1603), including obesity(16000)(1601), elevated blood pressure(1591)(1592), elevated fasting plasma glucose(1604)(1605), high serum triglycerides(1604)(1602), and low high-density lipoprotein (HDL)(1593)(1594)(1604) levels, insulin resistance(1606)(1607), proinflammation(1609)(1608) and renal damage(1610)(1611), reduced risk of cardiovascular disease(1612)(1613) and diabetes, probably through its effects on carbohydrate and lipid(1601) modulation via anti inflammatory(1606) and antioxidant(1603)(1606) mechanisms. All these factors may be the reasons of which garlic was recommended by modern traditional Chinese medicine doctors for management and treatment of PCOs' women who were diagnosed with kidney yang deficiency.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(1246) [Clinical study of area of Jiangsu province of polycystic ovarian syndrome correlation distribution of traditional Chinese medicine syndrome type and improper diet]. [Article in Chinese] by Feng Y, Gao YP.(PubMed)
(1247) [Preliminary study on relationship of disease-syndrome-symptom of ovulatory disorder infertility based on factor analysis]. [Article in Chinese] by Li M, Ma K, Shan, J.(PubMed)
(1247a) A Comprehensive Treatment of Polycystic Ovarian Syndrome (PCOS) bny by Liqin Zhao
(2072) Spleen, Earth
(2073) [Research on building method of spleen kidney Yang deficiency diarrhea rats model]. [Article in Chinese] by Pan X, Hu CJ, Geng YY, Zhao L, Wu WH, Wu XQ, Zhong ZD.(PubMed)
(2074) Treatment of an elderly patient with acute abdominal pain with traditional Korean medicine by Son CG1.(PubMed)
(2075) Shenzhu Tiaopi granule combined with lifestyle intervention therapy for impaired glucose tolerance: a randomized controlled trial by Fang Z1, Zhao J2, Shi G3, Shu Y3, Ni Y3, Wang H3, Ding L3, Lu R3, Li J3, Zhu X3, Cheng S4, Zhang X3, Liu Y5, Wang J6, Luo Y3, Fan Q3, Guo C3, Jiang T3, Wu Q3, Fan L3, Ling H3, Cui L3, Luo Y3, Yang H3, Anderson RM7.(PubMed)
(2075) Direct moxibustion to treat spleen qi and yang deficiency fatigue: a pilot study by Thorne TL1, Hanes DA2, Wild H3, Colbert A4.(PubMed)
(2076) [Clinical observation on fuzhong (supporting the middle-jiao) manipulation of tuina for infantile anorexia]. [Article in Chinese] by Wang YY, Liu XY.(PubMed)
(2077) [Effect of umbilicus moxibustion therapy on physical conditions of yang-deficiency volunteers]. [Article in Chinese] by Zhang YY1.(PubMed)
(2078) Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics by Zheng XF1, Tian JS2, Liu P3, Xing J1, Qin XM1.(PubMed)
(2079) [1H NMR based metabolomics study of bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model]. [Article in Chinese] by Chen L, Xiang H, Xing J, Tian JS, Qin XM, Du GH.(PubMed)
(2080) Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease by Dong Y1,2, Li Y3,4,5, Sun Y6, Mao J7, Yao F8, Tian Y9, Wang L10, Li L11, Li S12,13,14, Li J15,16,17(PubMed)
(2081) [Clinical observation on obesity and hyperlipidemia of liver qi stagnation and spleen deficiency pattern in female patients treated with combined therapy of acupuncture and tapping method]. [Article in Chinese] by Wu B, Liu ZC, Xu B.(PubMed)
(1585) Popular #Herbs - #Garlic (Allium sativum) by Kyle J. Norton
(1586) Da Suan, Garlic(Complementary and Alternative Healing University)
(1587) Garlic for the common cold by Lissiman E1, Bhasale AL, Cohen M.(PubMed)
(1588) Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey by Josling P1.(PubMed)
(1589) Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention by Nantz MP1, Rowe CA, Muller CE, Creasy RA, Stanilka JM, Percival SS.(PubMed)
(1590)A strategic call to utilize Echinacea-garlic in flu-cold seasons by Abdullah T.(PubMed)
(1591) Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials by Xiong XJ1, Wang PQ2, Li SJ3, Li XK4, Zhang YQ5, Wang J6.(PubMed)
(1592) Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial by Ried K1, Frank OR, Stocks NP.(PubMed)
(1593) Cholesterol-lowering effect of garlic extracts and organosulfur compounds: human and animal studies by Yeh YY1, Liu L.(PubMed)
(1594) Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic by Liu L1, Yeh YY.(PubMed)
(1595) A comparison of the antimicrobial activity of garlic, ginger, carrot, and turmeric pastes against Escherichia coli O157:H7 in laboratory buffer and ground beef by Gupta S1, Ravishankar S.(PubMed)
(1596) Antimicrobial activity of garlic, tea tree oil, and chlorhexidine against oral microorganisms by Groppo FC1, Ramacciato JC, Simões RP, Flório FM, Sartoratto A.(PubMed)
(1597) Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers by Fleischauer AT1, Poole C, Arab L.(PubMed)
(1598) Garlic and cancer: a critical review of the epidemiologic literature by Fleischauer AT1, Arab L.(PubMed)
(1599) Consumption of garlic and risk of colorectal cancer: an updated meta-analysis of prospective studies by Hu JY1, Hu YW1, Zhou JJ1, Zhang MW1, Li D1, Zheng S1.(PubMed)
(1600) Effect of garlic on high fat induced obesity by Kim MJ1, Kim HK.(PubMed)
(1601) Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress by Lai YS1, Chen WC, Ho CT, Lu KH, Lin SH, Tseng HC, Lin SY, Sheen LY.(PubMed)
(1602) Potential protective effects of Nigella sativa and Allium sativum against fructose-induced metabolic syndrome in rats by Al-Rasheed N1, Al-Rasheed N, Bassiouni Y, Faddah L, Mohamad AM.(PubMed)
(1603) Medicinal agents and metabolic syndrome by Rubio-Ruiz ME1, El Hafidi M, Pérez-Torres I, Baños G, Guarner V.(PubMed)
(1604) Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides by Thomson M1, Al-Qattan KK, Bordia T, Ali M.(PubMed)
(1605) Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subjects by Bakhsh R, Chughtai MI.(PubMed)
(1606) Attenuation of oxidative stress, inflammation and insulin resistance by allium sativum in fructose-fed male rats by K S1, Senthilkumar GP, Sankar P, Bobby Z.(PubMed)
(1607) Garlic improves insulin sensitivity and associated metabolic syndromes in fructose fed rats by Padiya R1, Khatua TN, Bagul PK, Kuncha M, Banerjee SK.(PubMed)
(1608) Alliin, a garlic (Allium sativum) compound, prevents LPS-inducedinflammation in 3T3-L1 adipocytes by Quintero-Fabián S1, Ortuño-Sahagún D2, Vázquez-Carrera M3, López-Roa RI4.(PubMed)
(1609) Diallyl trisulfide ameliorates arsenic-induced hepatotoxicity by abrogation of oxidative stress, inflammation, and apoptosis in rats by Sumedha NC1, Miltonprabu S2.(PubMed)
(1610) Aged garlic extract attenuates gentamicin induced renal damage and oxidative stress in rats by Maldonado PD1, Barrera D, Medina-Campos ON, Hernández-Pando R, Ibarra-Rubio ME, Pedraza-Chaverrí J.(PubMed)
(1611) Antioxidant S-allylcysteine prevents gentamicin-induced oxidative stress and renal damage by Maldonado PD1, Barrera D, Rivero I, Mata R, Medina-Campos ON, Hernández-Pando R, Pedraza-Chaverrí J.(PubMed)
(1612) Garlic and cardiovascular disease: a critical review by Rahman K1, Lowe GM.(PubMed)
(1613) Role of garlic usage in cardiovascular disease prevention: an evidence-based approach by Qidwai W1, Ashfaq T.(PubMed)
1 Takahide Ikeda,1 Kazuo Kajita,1 Kei Fujioka,1 Ichiro Mori,1 Hideyuki Okada,1 Yoshihiro Uno,1 and Tatsuo Ishizuka.(